Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06207253 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 30, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Notable Primary completion date: Feb 2025 to Dec 2025
    • Start date: Feb 2024 to Nov 2025
    • Study completion date: Sep 2025 to Dec 2025
    v3
  2. Minor Re-verified, no change to tracked fieldsv2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this randomized clinical trial is to evaluate the capability of the material to exert bacterial reduction of diclofenac sodium versus of that calcium hydroxide paste when these materials are used as intracanal medications in permanent molar teeth with chronic apical periodontitis. The main question\[s\] it aims to answer are: • Will the diclofenac sodium (NSAIDs) possess antimicrobial efficacy to be used effectively as an intracanal medicament similar to that of calcium hydroxide in primary endodontic treatment? Participants will be allocated randomly into three equal groups by using computer generated randomization, according to the type of intracanal medication.
Trial Details
NCT Number NCT06207253
Lead Sponsor British University In Egypt
Conditions
(from sponsor)
Endodontic Disease, Pulp Disease, Dental, Intracanal Medication
Related terms Dental Pulp Diseases, Periapical Periodontitis
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov